Biotechnology Industry Organization (BIO): New Bipartisan, Consensus Bill Points to Right Path to Biosimilars

WASHINGTON--(BUSINESS WIRE)--Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement regarding H.R. 1548, the Pathway to Biosimilars Act, introduced today by Rep. Anna Eshoo (D-CA), Rep. Jay Inslee (D-WA) and Rep. Joe Barton (R-TX) that would develop a regulatory pathway for approving biosimilars, medicines which are similar to pioneering biomedical therapies and treatments:
MORE ON THIS TOPIC